Incidence trends of esophageal squamous cell and adenocarcinoma in Finland in 2000–2021
DOI:
https://doi.org/10.2340/1651-226X.2025.44097Keywords:
Cancer epidemiology, incidence changes, Esophageal cancer, Esophageal squamous cell carcinoma, adenocarcinomaAbstract
Background and purpose: Esophageal cancer (EC) histological subtypes have contrasting incidence trends according to previous studies. In high-income countries, the incidence of esophageal squamous cell carcinoma (SCC) has decreased, while the incidence of esophageal adenocarcinoma (AC) has increased. This descriptive registry-based study evaluates incidence trends by EC subtype in Finland during 2000–2021.
Material and methods: Data on all EC cases by histological subtype, sex and 10-year age group diagnosed over the period 2000–2021 was obtained from the Finnish Cancer Registry. In total, 6,482 cases (2,604 AC, 2,979 SCC) were observed. Time trends by histology, sex and age group were evaluated with Poisson regression and joinpoint regression.
Results: EC incidence in men increased by an annual percentage change (APC) of 1.3 (95% confidence intervals [CI] 0.8–1.8) while no significant increase was observed in women with APC of -0.1, 95% CI -0.8–0.6). Incidence of AC in men increased with APC of 3.5 (95% CI 2.7–4.2) and by 2.0 (95% CI 0.4–3.6) in women. No consistent trends were observed in SCC incidence although in joinpoint regression, from 2000 to 2006 SCC incidence decreased in men by APC of -6.5 (95% CI -20.3 to -1.1). From 2006 to 2021, rates plateaued with APC of 0.9 (95% CI -0.4 to 7.2). No other joinpoints were identified.
Interpretation: EC incidence increased in Finland during 2000–2021 due to an increase in AC. Incidence of AC increased more than threefold in men, with a lesser increase in women. SCC incidence declined until 2006 and plateaued thereafter.
Downloads
References
Lagergren J, Smyth E, Cunningham D, Lagergren P. Oesophageal cancer. Lancet. 2017;390(10110):2383–96.
https://doi.org/10.1016/S0140-6736(17)31462-9 DOI: https://doi.org/10.1016/S0140-6736(17)31462-9
Gavin AT, Francisci S, Foschi R, Donnelly DW, Lemmens V, Brenner H, et al. Oesophageal cancer survival in Europe: a EUROCARE-4 study. Cancer Epidemiol. 2012;36(6):505–12. DOI: https://doi.org/10.1016/j.canep.2012.07.009
j.canep.2012.07.009 DOI: https://doi.org/10.1088/1475-7516/2012/07/009
Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020;13(6):1010–21.
https://doi.org/10.1007/s12328-020-01237-x DOI: https://doi.org/10.1007/s12328-020-01237-x
Morgan E, Soerjomataram I, Gavin AT, Rutherford MJ, Gatenby P, Bardot A, et al. International trends in oesophageal cancer survival by histological subtype between 1995 and 2014. Gut. 2021;70(2):234–42.
https://doi.org/10.1136/gutjnl-2020-321089 DOI: https://doi.org/10.1136/gutjnl-2020-321089
Edgren G, Adami HO, Weiderpass E, Nyrén O. A global assessment of the oesophageal adenocarcinoma epidemic. Gut. 2013;62(10):1406–14.
https://doi.org/10.1136/gutjnl-2012-302412 DOI: https://doi.org/10.1136/gutjnl-2012-302412
Sheikh M, Roshandel G, McCormack V, Malekzadeh R. Current status and future prospects for esophageal cancer. Cancers. 2023;15(3):765.
https://doi.org/10.3390/cancers15030765 DOI: https://doi.org/10.3390/cancers15030765
Leinonen MK, Miettinen J, Heikkinen S, Pitkäniemi J, Malila N. Quality measures of the population-based Finnish Cancer Registry indicate sound data quality for solid malignant tumours. Eur J Cancer. 2017;77:31–9.
https://doi.org/10.1016/j.ejca.2017.02.017 DOI: https://doi.org/10.1016/j.ejca.2017.02.017
European Commission. Eurostat. Revision of the European Standard Population: report of Eurostat’s task force : 2013 edition [Internet]. LU: Publications Office; 2013 [cited 2025 Feb 19]. Available from: https://data.europa.eu/doi/10.2785/11470
Lin Y, Wang H-L, Fang K, Zheng Y, Wu J. International trends in esophageal cancer incidence rates by histological subtype (1990–2012) and prediction of the rates to 2030. Esophagus. 2022;19(4):560–8.
https://doi.org/10.1007/s10388-022-00927-4 DOI: https://doi.org/10.1007/s10388-022-00927-4
Nordcan. Oesophagus cancer incidence [Internet]. IARC, NORDCAN, Association of the Nordic Cancer Registries. [cited 2025 Mar 30]. Available from: https://nordcan.iarc.fr/en/dataviz/trends?cancers=60&smoothing=20&num_path=2&show_dots=1&years=2000_2023
Abdulkarim D, Mattsson F, Lagergren J. Recent incidence trends of oesophago-gastric cancer in Sweden. Acta Oncol. 2022;61(12):1490–8.
https://doi.org/10.1080/0284186X.2022.2163592 DOI: https://doi.org/10.1080/0284186X.2022.2163592
Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, et al. The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology. 2022;163(3):649–58.e2. DOI: https://doi.org/10.1053/j.gastro.2022.05.054
j.gastro.2022.05.054 DOI: https://doi.org/10.1055/s-0042-1758381
Kroupa R, Katinova I, Pavlik T, Kunovsky L, Prochazka V, Borilova Linhartova P, et al. Incidence trends of esophageal cancer in the Czech Republic by histological subtype and stage and prescription rate of acid suppressing drugs. Cancer Epidemiol. 2020;69:101853.
https://doi.org/10.1016/j.canep.2020.101853 DOI: https://doi.org/10.1016/j.canep.2020.101853
Rodriguez GM, DePuy D, Aljehani M, Bien J, Lee JSH, Wang DH, et al. Trends in epidemiology of esophageal cancer in the US, 1975–2018. JAMA Netw Open. 2023;6(8):e2329497.
https://doi.org/10.1001/jamanetworkopen.2023.29497 DOI: https://doi.org/10.1001/jamanetworkopen.2023.29497
Lagergren J. Influence of obesity on the risk of esophageal disorders. Nat Rev Gastroenterol Hepatol. 2011;8(6):340–7.
https://doi.org/10.1038/nrgastro.2011.73 DOI: https://doi.org/10.1038/nrgastro.2011.73
World Obesity Federation [Internet]. Finland: Global Obesity Observatory. [cited 2025 Apr 4]. Available from: https://data.worldobesity.org/country/finland-70/#data_overview
Koskinas KC, Van Craenenbroeck EM, Antoniades C, Blüher M, Gorter TM, Hanssen H, et al. Obesity and cardiovascular disease: an ESC clinical consensus statement. Eur J Prev Cardiol. 2025;32(3): 184–220.
https://doi.org/10.1093/eurjpc/zwae279 DOI: https://doi.org/10.1093/eurjpc/zwae279
Li N, Yang WL, Cai MH, Chen X, Zhao R, Li MT, et al. Burden of gastroesophageal reflux disease in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of disease study 2019. BMC Public Health. 2023;23(1):582.
https://doi.org/10.1186/s12889-023-15272-z DOI: https://doi.org/10.1186/s12889-023-15272-z
When will Helicobacter pylori gastritis disappear in history in Finland? [Internet]. [cited 2025 Apr 4]. Available from: https://www.tandfonline.com/doi/epdf/10.1080/00365521.2021.1998605?needAccess=true
Xie SH, Lagergren J. The male predominance in esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2016;14(3):338–47.e1.
https://doi.org/10.1016/j.cgh.2015.10.005 DOI: https://doi.org/10.1016/j.cgh.2015.10.005
Sihvo EI, Salminen JT, Rämö OJ, Salo JA. The epidemiology of oesophageal adenocarcinoma: has the cancer of gastric cardia an influence on the rising incidence of oesophageal adenocarcinoma? Scand J Gastroenterol. 2000;35(10):1082–6.
https://doi.org/10.1080/003655200451216 DOI: https://doi.org/10.1080/003655200451216
Lindblad M, Ye W, Lindgren A, Lagergren J. Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann Surg. 2006;243(4):479–85.
https://doi.org/10.1097/01.sla.0000205825.34452.43 DOI: https://doi.org/10.1097/01.sla.0000205825.34452.43
Wang QL, Xie S-H, Wahlin K, Lagergren J. Global time trends in the incidence of esophageal squamous cell carcinoma. Clin Epidemiol. 2018;10:717–28.
https://doi.org/10.2147/CLEP.S166078 DOI: https://doi.org/10.2147/CLEP.S166078
Kolstad A, Emanuel G, Hjortland GO, Nilssen Y, Ulvestad M, Areffard A, et al. Long-term trends in the clinical management and outcomes of patients with gastroesophageal cancer in Norway. Acta Oncol. 2025;64:540–9.
https://doi.org/10.2340/1651-226X.2025.43167 DOI: https://doi.org/10.2340/1651-226X.2025.43167
Prabhu A, Obi KO, Rubenstein JH. The synergistic effects of alcohol and tobacco consumption on the risk of esophageal squamous cell carcinoma: a meta-analysis. Am J Gastroenterol. 2014;109(6):822–7.
https://doi.org/10.1038/ajg.2014.71 DOI: https://doi.org/10.1038/ajg.2014.71
Kauppila JH. Completeness of esophageal cancer diagnosis in the Finnish Cancer Registry and hospital discharge registry, a nationwide study in Finland. Acta Oncol. 2020;59(11):1329–32.
https://doi.org/10.1080/0284186X.2020.1792547 DOI: https://doi.org/10.1080/0284186X.2020.1792547
Additional Files
Published
How to Cite
License
Copyright (c) 2025 Pietari Junkala, Anssi Auvinen
This work is licensed under a Creative Commons Attribution 4.0 International License.
